BROWSE BY STUDY TYPE OR CONFERENCE
All
- All
- MODEL VALIDATION
- CLINICAL VALIDATION
- AACR
- ASCO
- ASH
BROWSE BY YEAR
All
- All
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- Archive
Superior therapy response predictions for patients with myelodysplastic syndrome (MDS) using Cellworks Singula: MyCare-009-02
ASCO Meeting Library,
Superior therapy response predictions for patients with glioblastoma (GBM) using Cellworks Singula: MyCare-009-03
ASCO Meeting Library,
Superior therapy response predictions for patients with low-grade glioma (LGG) using Cellworks Singula: MyCare-009-04
ASCO Meeting Library,
Superior therapy response predictions for patients with pancreatic cancer (PDAC) using Cellworks Singula: MyCare-009-05
ASCO Meeting Library,
Combination chemotherapy versus temozolomide (TMZ) for patients with MGMT methylated (m-MGMT) glioblastoma (GBM): Results of cellworks omics biosimulation—myCare-015
ASCO Meeting Library,
Prediction of Outcomes With a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated With Radiation Therapy and Temozolomide
International Journal of Radiation Oncology, Biology, Physics,
A Feasibility Study of Biologically Focused Therapy for Myelodysplastic Syndrome Patients Refractory to Hypomethylating Agents
ASH Annual Meeting,
Role of mTOR Inhibitor Everolimus in the Treatment of Metastatic Thymic Epithelial Tumors